Local Administration of Low-Dose Nerve Growth Factor Antibody Reduced Pain in a Rat Osteoarthritis Model

Systemic injection of a nerve growth factor (NGF) antibody has been proven to have a significant relevance in relieving osteoarthritis (OA) pain, while its adverse effects remain a safety concern for patients. A local low-dose injection is thought to minimize adverse effects. In this study, OA was i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yuan, Onodera, Tomohiro, Terkawi, Mohamad Alaa, Iwasaki, Koji, Hishimura, Ryosuke, Liang, Dawei, Miyazaki, Takuji, Iwasaki, Norimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962042/
https://www.ncbi.nlm.nih.gov/pubmed/33806315
http://dx.doi.org/10.3390/ijms22052552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962042/
https://www.ncbi.nlm.nih.gov/pubmed/33806315
http://dx.doi.org/10.3390/ijms22052552

Ejemplares similares